Table 3.

Final adjusted logistic regression model

	b	OR	CI 95%		p value
Present vs. Absent
Age, years	0.028	1.03	1.02	1.04	< 0.001
Duration of DM, years	0.067	1.07	1.05	1.09	< 0.001
HbA1c (%)	0.216	1.24	1.17	1.32	< 0.001
Serum uric acid, mg/dL	0.196	1.22	1.13	1.31	< 0.001
Use of an angiotensin-converting enzyme (ACE) inhibitor, yes	0.563	1.78	1.26	2.43	< 0.001
Macrovascular disease, yes	0.813	2.26	1.08	4.71	0.03
Arterial hypertension, yes	0.521	1.68	1.13	2.5	0.01
VTDR vs. Non-VTDR
Duration of DM, years	0.075	1.08	1.06	1.1	< 0.001
HbA1c %	0.105	1.11	1.02	1.21	0.014
Serum uric acid, mg/dL	0.219	1.25	1.13	1.37	< 0.001
Use of an angiotensin-converting enzyme (ACE) inhibitor yes	0.774	2.17	1.51	3.11	< 0.001
LDL cholesterol, mg/dL	−0.01	0.99	0.99	1	0.019
Chronic kidney disease, yes	0.925	2.52	1.69	3.77	< 0.001

VTDR vision-threatening diabetic retinopathy, HbA1c glycated hemoglobin, LDL-c low density lipoprotein cholesterol, b coefficient for logistic regression; OR odds ratio, CI 95% 95% confidence interval